ARCHIVES

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

Peer Review Study Team Plans Hearing

December 12, 1975

Fy 1981 Budget Breakdown B Mechanism, Activity

February 1, 1980

CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome

April 22, 1983

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

Mammography Screening For Ages 40-49 Not Supported By Data, NIH Pane! Says

January 31, 1997